<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8020">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00864682</url>
  </required_header>
  <id_info>
    <org_study_id>06091</org_study_id>
    <nct_id>NCT00864682</nct_id>
  </id_info>
  <brief_title>Preventing Propofol-associated Injection Pain</brief_title>
  <official_title>Propofol Mixed With Lidocaine Versus Lidocaine Pretreatment With Tourniquet for Alleviation of Pain Associated With Propofol Injection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Benaroya Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Benaroya Research Institute</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Injection of propofol is associated with discomfort in subsets of patients. Local
      anesthetics have been shown to attenuate this response in some patients. This randomized,
      double-blind, placebo-controlled trial tests the hypothesis that lidocaine mixed with
      propofol will be superior to lidocaine administered directly into the vein, under tourniquet
      control, prior to injection of propofol. Both groups are expected to be superior to placebo.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Verbal Pain Score</measure>
    <time_frame>Immediately after injection of study drug. One time assessment.</time_frame>
    <safety_issue>No</safety_issue>
    <description>11 point verbal pain score (VPS) 0=no pain; 10=worst imaginable pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complete Alleviation of Injection Pain</measure>
    <time_frame>Immediately after injection of study drug. One time assessment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total subjects within the arm versus those subjects who had no pain with injection (VPS=0)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Anesthetic Technique</measure>
    <time_frame>Prior to discharge. One time assessment</time_frame>
    <safety_issue>No</safety_issue>
    <description>Were you satisfied with the anesthetic technique? Yes/No</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">156</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline pretreatment, saline admixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine pretreatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine pretreatment / saline-propofol admixture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine-Propofol admixture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>saline pretreatment / Lidocaine-propofol admixture</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>3.3 mL normal saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine / propofol admixture</intervention_name>
    <description>lidocaine 50 mg plus propofol 50 mg intravenous (iv)</description>
    <arm_group_label>Lidocaine-Propofol admixture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lidocaine pretreatment</intervention_name>
    <description>lidocaine 50 mg iv under tourniquet-control</description>
    <arm_group_label>Lidocaine pretreatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  weight &gt;40kg, &lt;100kg

          -  ambulatory surgery

        Exclusion criteria:

          -  allergy to propofol or lidocaine

          -  taking opioids, benzodiazepines, or nonsteroidal antiinflammatory drugs (NSAIDs)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph M Neal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Mason Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Benaroya Research Institute</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <lastchanged_date>February 4, 2012</lastchanged_date>
  <firstreceived_date>March 16, 2009</firstreceived_date>
  <firstreceived_results_date>March 24, 2009</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Benaroya Research Institute</investigator_affiliation>
    <investigator_full_name>Joseph Neal</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>lidocaine</keyword>
  <keyword>injection pain</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Patients entered were recruited between January 2008 and March 2009. Hospital / ambulatory surgery setting</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Control Arm</title>
          <description>saline pretreatment, saline plus propofol admixture</description>
        </group>
        <group group_id="P2">
          <title>Lidocaine / Propofol Admixture Arm</title>
          <description>saline pretreatment, lidocaine plus propofol admixture</description>
        </group>
        <group group_id="P3">
          <title>Lidocaine Pretreatment Arm</title>
          <description>lidocaine pretreatment, saline plus propofol admixture</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
                <participants group_id="P2" count="51"/>
                <participants group_id="P3" count="53"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
                <participants group_id="P3" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Arm</title>
          <description>saline pretreatment, saline plus propofol admixture</description>
        </group>
        <group group_id="B2">
          <title>Lidocaine / Propofol Admixture Arm</title>
          <description>saline pretreatment, lidocaine plus propofol admixture</description>
        </group>
        <group group_id="B3">
          <title>Lidocaine Pretreatment Arm</title>
          <description>lidocaine pretreatment, saline plus propofol admixture</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="52"/>
                <measurement group_id="B2" value="51"/>
                <measurement group_id="B3" value="53"/>
                <measurement group_id="B4" value="156"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
                <measurement group_id="B4" value="0.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="42"/>
                <measurement group_id="B2" value="41"/>
                <measurement group_id="B3" value="38"/>
                <measurement group_id="B4" value="121.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
                <measurement group_id="B2" value="10"/>
                <measurement group_id="B3" value="15"/>
                <measurement group_id="B4" value="35.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="53" spread="14"/>
                <measurement group_id="B2" value="54" spread="14"/>
                <measurement group_id="B3" value="52" spread="17"/>
                <measurement group_id="B4" value="53" spread="15"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="30"/>
                <measurement group_id="B2" value="23"/>
                <measurement group_id="B3" value="26"/>
                <measurement group_id="B4" value="79.0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="22"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="27"/>
                <measurement group_id="B4" value="77.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="52"/>
                <measurement group_id="B2" value="51"/>
                <measurement group_id="B3" value="53"/>
                <measurement group_id="B4" value="156.0"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Verbal Pain Score</title>
        <description>11 point verbal pain score (VPS) 0=no pain; 10=worst imaginable pain</description>
        <time_frame>Immediately after injection of study drug. One time assessment.</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>saline pretreatment, saline plus propofol admixture</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine / Propofol Admixture Arm</title>
            <description>saline pretreatment, lidocaine plus propofol admixture</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine Pretreatment Arm</title>
            <description>lidocaine pretreatment, saline plus propofol admixture</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="50"/>
                  <measurement group_id="O2" value="50"/>
                  <measurement group_id="O3" value="51"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Verbal Pain Score</title>
            <description>11 point verbal pain score (VPS) 0=no pain; 10=worst imaginable pain</description>
            <units>Units on a scale</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="3" lower_limit="0" upper_limit="6"/>
                  <measurement group_id="O2" value="0" lower_limit="0" upper_limit="2"/>
                  <measurement group_id="O3" value="0" lower_limit="0" upper_limit="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Hypothesis: Lidocaine / propofol admixture would be superior to lidocaine pretreatment for attenuating propofol-induced injection pain. Sample size calculated to detect a difference of at least 2 VPS points; beta 0.8.</groups_desc>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.0001</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Complete Alleviation of Injection Pain</title>
        <description>Total subjects within the arm versus those subjects who had no pain with injection (VPS=0)</description>
        <time_frame>Immediately after injection of study drug. One time assessment</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>saline pretreatment, saline plus propofol admixture</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine / Propofol Admixture Arm</title>
            <description>saline pretreatment, lidocaine plus propofol admixture</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine Pretreatment Arm</title>
            <description>lidocaine pretreatment, saline plus propofol admixture</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="50"/>
                  <measurement group_id="O2" value="50"/>
                  <measurement group_id="O3" value="51"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Complete Alleviation of Injection Pain</title>
            <description>Total subjects within the arm versus those subjects who had no pain with injection (VPS=0)</description>
            <units>Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="14"/>
                  <measurement group_id="O2" value="28"/>
                  <measurement group_id="O3" value="40"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority>No</non_inferiority>
            <p_value>&lt;0.008</p_value>
            <method>Chi-squared</method>
            <method_desc>Fisher's exact test after chi-squared</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Anesthetic Technique</title>
        <description>Were you satisfied with the anesthetic technique? Yes/No</description>
        <time_frame>Prior to discharge. One time assessment</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Control Arm</title>
            <description>saline pretreatment, saline plus propofol admixture</description>
          </group>
          <group group_id="O2">
            <title>Lidocaine / Propofol Admixture Arm</title>
            <description>saline pretreatment, lidocaine plus propofol admixture</description>
          </group>
          <group group_id="O3">
            <title>Lidocaine Pretreatment Arm</title>
            <description>lidocaine pretreatment, saline plus propofol admixture</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="50"/>
                  <measurement group_id="O2" value="50"/>
                  <measurement group_id="O3" value="51"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Satisfaction With Anesthetic Technique</title>
            <description>Were you satisfied with the anesthetic technique? Yes/No</description>
            <units>Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Yes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="42"/>
                  <measurement group_id="O2" value="48"/>
                  <measurement group_id="O3" value="51"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>No</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="8"/>
                  <measurement group_id="O2" value="2"/>
                  <measurement group_id="O3" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Control Arm</title>
          <description>saline pretreatment, saline plus propofol admixture</description>
        </group>
        <group group_id="E2">
          <title>Lidocaine / Propofol Admixture Arm</title>
          <description>saline pretreatment, lidocaine plus propofol admixture</description>
        </group>
        <group group_id="E3">
          <title>Lidocaine Pretreatment Arm</title>
          <description>lidocaine pretreatment, saline plus propofol admixture</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="52"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Joseph M. Neal, MD</name_or_title>
      <organization>Virginia Mason Medical Center</organization>
      <phone>206-223-6980</phone>
      <email>anejmn@vmmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
